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Abstract
Introduction:  As  obesity  is  currently  a  major  public  health  problem,  bariatric  surgery  has  been
widely indicated  due  to  the  difﬁculties  involved  in  the  clinical  management  of  obese  adults.
Objectives:  Assess  the  quality-of-life  (QOL)  of  patients  who  had  undergone  Roux-en-Y  Gastric
Bypass (RYGB)  in  the  State  of  Goiás,  Brazil,  where  as  yet  no  studies  have  been  published  on  the
QOL of  patients  who  underwent  bariatric  surgery.
Methods:  A  retrospective  study,  using  the  Bariatric  Analysis  and  Reporting  Outcome  System
(BAROS),  was  carried  out  in  Goiânia  and  Rio  Verde,  Goiás,  Brazil,  with  50  over  18-year-old
patients of  both  genders,  who  had  undergone  RYGB  and  had  at  least  three  months  of  postop-
erative time.
Results:  Before  RYGB,  48%  of  the  individuals  were  classiﬁed  as  morbidly  obese.  Average
weight and  body  mass  index  (BMI)  of  the  50  patients  interviewed  were  119.37  ±  18.44  kg  and
43.54 ±  5.33  kg/m2,  respectively.  By  contrast,  after  the  RYGB  these  parameters  decreased  sig-
niﬁcantly  to  78.01  ±  11.06  kg  and  28.46  ±  3.61  kg/m2,  respectively,  mainly  from  the  3rd  to  85th
month of  postoperative  time  (p  <  0.0001).  As  well  as  that,  78%  reported  having  presented  pre-
operative comorbidities,  especially  hypertension  (44%),  rheumatism  (34%),  dyslipidemia  (24%)
and diabetes  (20%).  However,  after  surgery,  the  resolution  rates  were  77,  24,  100  and  100%,
respectively,  for  these  same  clinical  conditions.  In  terms  of  QOL,  some  patients  reported  feel-
ing better  (8%)  or  much  better  (92%)  after  RYGB.  The  outcome  of  the  BAROS  method  for  those
patients was  classiﬁed  as  fair  (2%),  good  (8%),  very  good  (24%)  and  excellent  (66%).∗ Corresponding authors.
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Conclusions:  Preliminary  results  indicated  that  RYGB  could  be  a  successful  surgical  procedure
to promote  satisfactory  and  sustained  reduction  in  the  body  measurements  of  morbidly  obese
patients from  Goiás,  Brazil.  Furthermore,  the  ﬁnal  BAROS  score  showed  improvements  in  asso-
ciated comorbidity  and  also  in  the  QOL  of  these  patients.
© 2015  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  España,  S.L.U.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Impacto  da  Cirurgia  Bariátrica  em  Pacientes  de  Goiás,  Brasil,  Usando  Metodologia
BAROS  -- Um  Estudo  Preliminar
Resumo
Introduc¸ão:  Como  a  obesidade  é  atualmente  um  grande  problema  de  saúde  pública,  a  cirurgia
bariátrica  tem  sido  amplamente  indicada  devido  às  diﬁculdades  envolvidas  no  manejo  clínico
de adultos  obesos.
Objetivos:  Avaliar  a  qualidade  de  vida  (QDV)  de  pacientes  submetidos  ao  Desvio  Gástrico  em  Y-
de-Roux (DGYR)  no  Estado  de  Goiás,  Brasil,  onde  ainda  não  há  estudos  sobre  a  QDV  de  pacientes
submetidos  à  cirurgia  bariátrica.
Métodos:  Um  estudo  retrospectivo,  utilizando  o  Bariatric  Analysis  and  Reporting  Outcome  Sys-
tem (BAROS),  foi  realizado  em  Goiânia  e  Rio  Verde,  Goiás,  Brasil,  com  50  pacientes  com  idade
superior a  18  anos,  de  ambos  os  gêneros,  que  realizaram  DGYR  com  tempo  pós-operatório
mínimo  de  três  meses.
Resultados:  Antes  da  DGYR,  48%  dos  indivíduos  foram  classiﬁcados  como  obesos  mórbidos.
A média  de  peso  e  índice  de  massa  corporal  (IMC)  dos  50  pacientes  entrevistados  foram
119,37 ±  18,44Kg  e  43,54  ±  5,33Kg/m2,  respectivamente.  Em  contrapartida,  após  a  DGYR,  esses
parâmetros  diminuíram  signiﬁcativamente  para  78,01  ±  11,06  kg  e  28,46  ±  3,61  kg/m2,  respec-
tivamente,  principalmente  do  3◦ ao  85◦ mês  de  tempo  pós-operatório  (p  <  0.0001).  Além  disso,
78% reportaram  tendo  apresentado  comorbidades  pré-operatórias,  especialmente  hipertensão
(44%), reumatismo  (34%),  dislipidemia  (24%)  e  diabetes  (20%).  Entretanto,  após  a  cirurgia,  as
taxas de  resoluc¸ão  foram  de  77,  24,  100  e  100%,  respectivamente,  para  essas  mesmas  condic¸ões
clínicas.  Em  termos  de  QDV,  alguns  pacientes  relataram  se  sentir  melhor  (8%)  ou  muito  melhor
(92%) após  a  DGYB.  O  resultado  do  método  BAROS  para  esses  pacientes  foi  classiﬁcado  como
insuﬁciente  (2%),  bom  (8%),  muito  bom  (24%)  e  excelente  (66%).
Conclusões:  Resultados  preliminares  indicaram  que  a  DGYB  pode  ser  um  procedimento  cirúr-
gico para  promover  com  sucesso  a  reduc¸ão  satisfatória  e  sustentada  nas  medidas  corporais  de
pacientes  com  obesidade  mórbida  provenientes  de  Goiás,  Brasil.  Além  disso,  a  pontuac¸ão  ﬁnal
do BAROS  mostrou  melhorias  das  comorbidades  associadas  e  também  na  QDV  desses  pacientes.
© 2015  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  España,  S.L.U.  Este  é
um artigo  Open  Access  sob  a  licença  de  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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i. Introduction
besity  which  is  responsible  for  comorbidities  such
s  diabetes,  ischemic  heart  disease,  hypertension  and
therosclerosis,  is  currently  a  major  public  health  problem
f  great  prevalence.  Furthermore,  overall  mortality  due  to
his  clinical  condition  has  increased  over  the  years.1,2
Consequently,  dietary  and  pharmacotherapeutic  treat-
ents  are  undertaken  for  weight  loss  and  maintenance.
owever,  studies  have  shown  that  clinical  and  nutritional
reatment  present  no  signiﬁcant  result  in  the  long  term.
ence,  bariatric  surgery  has  been  widely  indicated  due
o  the  difﬁculties  involved  in  the  clinical  management  of
everely  obese  adults.3--7
M
g
iThe  main  beneﬁts  accruing  from  this  surgery  are  the
esolution  of  comorbidities,  weight  loss  and  maintenance,
ll  of  which  lead  to  an  improvement  in  the  quality-
f-life.8,9 Furthermore,  expenditure  involving  medicines,
ealth  professionals  and  tests  progressively  decrease  after
he  operation.  This  is  more  evident  in  patients  with  more
omorbidity.  Therefore,  this  surgery  produces  substantial
conomic  beneﬁts  for  health  systems  and/or  patients,
hich,  in  turn,  compensate  for  the  considerable  expenses
nvolved  in  undergoing  bariatric  surgery.10--12Resolution  1.942/2010  of  Brazil’s  Federal  Council  of
edicine’s13 presents  the  accepted  procedures  for  this  sur-
ical  practice,  in  which  the  Roux-en-Y  Gastric  Bypass  (RYGB)
s  widely  recommended  (40%).14
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RYGB  provides  proper  and  long-lasting  weight  loss  in
conjunction  with  low  failure  rates  and  few  long-term
complications.  Nutritional  and  metabolic  accompaniment  of
the  patient  is  easy  and  the  surgery  is  reversible,  although
this  involves  certain  technical  difﬁculties.  In  addition,  it
presents  excellent  results  in  terms  of  improved  quality-of-
life  and  treatment  of  related  diseases.13
However,  the  literature  highlights  certain  postoperative
complications  such  as  dumping  syndrome  (nausea,  vomiting,
ﬂushing,  abdominal  pain  and  symptoms  of  hypoglycemia),
gastric  obstruction,  rupture  of  the  staple  line  and  some
speciﬁc  micronutrient  deﬁciencies,  which  demand  ade-
quate  nutritional  intervention.15 In  addition,  such  patients
are  classiﬁed  with  lower  quality-of-life.  Thus,  efﬁcient
approaches  are  needed  to  ensure  weight  reduction  and  also
to  improve  quality-of-life  of  patients  who  have  undergone
RYGB.
Assessment  of  the  effectiveness  of  surgical  treatment
requires  speciﬁc  and  appropriate  evaluation  methods  given
all  the  variables  which  inﬂuence  the  outcome  of  bariatric
surgery.16 Hence,  it  is  important  to  use  standardized
and  reliable  methods,  such  as  the  Bariatric  Analysis  and
Reporting  Outcome  System  (BAROS)  proposed  by  Oria  and
Moorehead.17
Given  this  scenario,  this  preliminary  study  evaluated  the
effectiveness  and  impact  of  RYGB  bariatric  surgery  on  the
quality-of-life  of  patients  in  two  locations  in  the  State  of
Goiás,  Brazil,  using  the  BAROS  method.
2. Materials and methods
A  retrospective  study  was  carried  out,  in  Goiânia  and  Rio
Verde,  Goiás,  Brazil,  with  50  over  18-year-old  patients  of
both  genders,  who  had  undergone  RYGB  and  had  at  least
three  months  of  postoperative  time.  These  towns  represent,
respectively,  the  Central  and  Southern  mesoregions  of  Goiás,
a  state  where  to  date,  no  studies  have  been  published  on
the  quality-of-life  of  patients  who  have  undergone  bariatric
surgery.
After  approval  by  the  Research  Ethics  Committee  of  the
Federal  University  of  Goiás,  Brazil  (FUG  no.  048/2012),
periodic  visits  to  public  and  private  health  facilities  were
conducted  to  invite  patients  who  had  undergone  RYGB  to
participate  in  this  study.  The  invitation  was  realized  by
chance  for  patients  that  we  found  in  the  health  facilities  dur-
ing  the  days  visited.  When  it  was  not  possible  to  interview  a
patient  while  waiting  for  their  consultation,  they  were  inter-
viewed  later  and  were  also  asked  if  they  knew  other  patients
who  had  RYGB.  A  total  of  55  patients  were  invited  to  par-
ticipate  in  this  study,  two  of  whom  refused  for  unexplained
reasons.
Interviews  were  conducted  between  July  and  August
2012,  after  each  respondent  had  completed  the  Free  and
Clariﬁed  Consent  Term,  using  the  BAROS  questionnaire
(Appendix).  All  information  used  in  the  research  was  pro-
vided  by  the  patients,  thus  clinical  charts  were  not  assessed.
The  hospitals  involved  are  accredited  for  bariatric  surgery.The  BAROS  questionnaire17 quantitatively  evaluates  the
quality-of-life  of  patients  who  have  undergone  bariatric
surgery  for  the  long  term  treatment  of  obesity  in  three  main
areas:  percentage  of  excess  weight  loss  (%EWL),  changes
c
(
r
f95
n  medical  conditions  (comorbidities)  and  quality-of-life.
t  considers  self-esteem,  physical  activities,  social  rela-
ionships,  willingness  to  work  and  sexual  interest.  The
ystem  deﬁnes  ﬁve  outcome  groups  (failure,  fair,  good,
ery  good,  and  excellent),  based  on  a  scoring  table  which
dds  or  subtracts  points  in  accordance  with  the  existence
f  complications  and/or  reoperation  while  evaluating  the
hree  main  areas  described  above.  As  adapted  from  Oria  and
oorehead,17 Table  1  shows  the  criteria  used  in  the  evalua-
ion  of  resolution  or  improvement  of  the  comorbidities  after
YGB  of  the  patients  interviewed  in  this  study.
Of  the  53  patients  interviewed,  50  met  the  inclusion
riteria  for  the  study:  over  18  female  or  male  patients,  who
ad  undergone  RYGB  at  least  three  months  previously.  The
xclusion  criteria  meant  that  patients  under  18,  who  had
ndergone  bariatric  surgery  less  than  three  months  previ-
usly  (n  =  1)  and  individuals  operated  with  other  types  of
ariatric  surgery  such  as  sleeve  gastrectomy  (n  =  2)  were  not
ncluded.
The  distribution  data  of  patients  was  performed  using
escriptive  statistics:  mean,  standard  deviation,  minimum
nd  maximum  values,  absolute  and  relative  data,  numeric
nd  percentile  values.  The  inter  group  variation  was  mea-
ured  by  the  one-way  analysis  of  variance  (ANOVA)  or
wo-way  ANOVA  followed  by  the  Bonferroni  test.  Statistical
igniﬁcance  was  set  at  p  <  0.05.
.  Results
f  the  patients  interviewed  after  RYGB  bariatric  surgery,  13
26%)  were  from  Rio  Verde  and  37  (74%)  from  Goiânia.  In  the
ormer  group,  15  and  85%  were  male  and  female,  respec-
ively,  while  in  the  latter  this  frequency  was  22  and  78%,
n  the  same  order.  These  patients  were  stratiﬁed  according
o  the  time  of  surgery  (3  months  minimum  of  postoperative
ime):  (A)  3--12  months  (n  =  14);  (B)  13--36  months  (n  =  13);
C)  37--60  months  (n  =  12);  (D)  61--85  months  (n  =  8);  (E)  over
00  months  (n  =  3).  Age  ranged  from  22  to  59,  with  a  mean  of
9.6  years.  Education  level,  nutritional  condition  and  mari-
al  status  are  presented  in  Table  2.
A  total  of  78%  reported  having  presented  comorbidi-
ies  prior  to  bariatric  surgery.  As  shown  in  Table  3,  the
ost  prevalent  comorbidities  presented  prior  to  the  surgical
rocedure  were  hypertension  (44%),  rheumatism  (arthritis
nd  osteoarthritis)  (34%),  dyslipidemia  (24%)  and  diabetes
20%).  On  the  other  hand,  all  respondents  who  had  diabetes
efore  the  bariatric  surgery  reported  not  using  diabetes
edications  due  to  resolution  of  this  condition  by  RYGB.
imilar  ﬁndings  were  observed  in  patients  who  had  dys-
ipidemia.  Regarding  hypertension,  patients  showed  77%
f  resolution.  Moreover,  90%  of  patients  reported  resolu-
ion  of  sleep  apnea,  while  76%  showed  improvement  of
heumatism.  Additionally,  other  clinical  conditions  were  also
mproved  or  resolved  by  surgery.
However,  60%  of  respondents  said  they  experienced  cer-
ain  complications.  There  was  a  higher  prevalence  of  minor
omplications,  such  as  dumping  syndrome  (36%)  and  anemia
14%),  than  of  severe  complications.  In  addition,  a  reduced
eoperation  rate  (6%)  was  found,  but  only  in  the  case  of
emale  patients.
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Table  1  Criteria  used  in  the  evaluation  of  resolution  or  improvement  of  the  comorbidities  after  RYGB  of  the  patients  interviewed
from Rio  Verde  and  Goiânia,  Brazil,  who  had  undergone  RYGB  bariatric  surgery.
Clinical  condition  Resolution  Improvement
Borderline  cholesterol  levels  No  medication  Normalized  by  diet
Chondromalacia  No  medication  Normalized  by  medication/pain
reduction
Depression  No  medication  Controlled  by  psychological
counseling/medication  reduction
Diabetes Diet/exercise  only  No  insulin  necessary
Disc herniation  No  medication  Normalized  by  medication
Dyslipidemia No  medication Normalized  by  medication
Dyspnea Absence  Frequency  reduction
Female infertility Pregnancy Regular  menses
Glucose tolerance  No  medication  Controlled  by  diet/exercise
Hiatal hernia  No  medication  Normalized  by  medication
Hypertension  Diet/diuretic  only  or  no  medication  Controlled  by  medication
Hypothyroidism  No  medication  Asymptomatic,  but  it  needs
medication
Insomnia No  medication  Normalized  by  medication
Oscillation of  blood  pressure  No  medication  Normalized  by  medication
Panic syndrome  No  medication  Normalized  by  medication
Peripheral vascular  disease  No  medication  Normalized  by  medication
Pre-diabetes No  medication  Normalized  by  diet
Protrusion of  the  vertebra  No  medication/physiotherapy  Normalized  by  medication
Rheumatism (arthritis  and  osteoarthritis)  No  medication  Controlled  by  medication
Sleep apnea  Normalized  Apneas/hour:  5--15
Steatosis No  medication  Reduced  fat  levels
Table  2  Characterization  of  patients  interviewed  from  Rio  Verde  and  Goiânia,  Brazil,  who  had  undergone  RYGB  bariatric  surgery.
In relation  to  nutritional  status,  the  obesity  level  of  patients  was  categorized  as  following:  grade  I  (30  <  IMC  <  34.9  kg/m2),  II
(35 <  IMC  <  39.9  kg/m2),  III  (40  <  IMC  <  49.9  kg/m2)  and  superobese  (IMC  >  50  kg/m2).
Nutritional  status  (%)  Marital  status  (%)  Schooling  level  (%)
Grade  I  (2)  Single  (34)  Incomplete  elementary  school  (8)
Grade II  (34)  Married  (52)  Complete  elementary  school  (4)
Grade III  (48)  Divorced  (10)  Complete  high  school  (12)
Superobese (16)  Widowed  (4)  Incomplete  higher  education  (10)
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iWith  regard  to  weight  and  body  mass  index  (BMI),  there
as  a  signiﬁcant  reduction  in  both  parameters  after  the
YGB  bariatric  surgery,  mainly  from  the  3rd  to  85th  month
f  postoperative  time  (groups  A--D)  (p  <  0.0001)  (Table  4).
n  addition,  the  EWL  percentage  was  signiﬁcantly  higher
p  < 0.0001),  greater  than  50%  in  group  A  and  80%  in  groups
--E  (Fig.  1).
In terms  of  quality-of-life  aspects,  some  patients
eported  feeling  better  (8%)  or  much  better  (92%)  after
urgery.  In  addition,  8%  stated  that  their  physical  activi-
ies  had  decreased,  28%  said  that  they  remained  stable,
hile  the  remaining  64%  said  that  they  had  increased.
urthermore,  2%  reported  that  they  were  attending  less
ocial  and  family  gatherings.  Others  stated  that  nothing  had
hanged  in  this  respect  (32%),  while  a  larger  number  said
hat  their  social  activities  had  increased  (66%).  A  small  num-
er  of  interviewees  reported  that  their  working  capacity  had
educed  (2%)  or  remained  unchanged  (12%),  while,  on  the
m
s
u
rComplete  higher  education  (66)
ther  hand,  86%  said  theirs  had  improved.  On  the  question
f  sexual  activity,  several  patients  declared  that  their  inter-
st  was  the  same  (28%)  or  higher  (68%),  while  a  minority  (4%)
eported  a  decrease.
So  in  terms  of  the  BAROS  method,  the  outcome  for  those
atients  who  had  undergone  RYGB  bariatric  surgery  was  clas-
iﬁed  as  fair  (2%),  good  (8%),  very  good  (24%)  and  excellent
66%)  (Fig.  2).
. Discussion
n  recent  years,  the  popularity  of  bariatric  surgery  has
ncreased  and  RYGB  had  been  classiﬁed  as  the  most  com-
on  weight  loss  procedure.18 In  view  of  that,  a  retrospective
tudy  of  quality-of-life  was  carried  out  with  50  patients  who
nderwent  RYGB  in  Goiânia  and  Rio  Verde,  Goiás,  Brazil,  a
egion  where  no  studies  had  previously  been  published  on
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Table  3  Comorbidities  and  other  clinical  conditions  presented  before  RYGB  bariatric  surgery,  and  complications  reported
afterwards in  patients  from  Rio  Verde  and  Goiânia,  Goiás,  Brazil.
Comorbidities  (%)  Complications  (%)
Before  RYGB  After  RYGB
Improved  Resolved
Sleep  apnea  (20)  Sleep  apnea  (2)  Sleep  apnea  (18)  Anemia  (14)
Chondromalacia  (2)  Peripheral  vascular
disease  (2)
Chondromalacia  (2)  Stroke  (2)
Peripheral  vascular
disease  (4)
Depression  (4)  Peripheral  vascular  disease
(2)
Deﬁciency  of  minerals  and
vitamins  (8)
Depression (8)  Hypertension  (10)  Depression  (4)  Diarrhea  (6)
Diabetes (20)  Rheumatism  (arthritis
and osteoarthritis)  (26)
Diabetes  (20)  Flatulence  (4)
Dyslipidemia  (24)  Panic  syndrome  (4)  Dyslipidemia  (24)  Intraperitoneal  hemorrhage
with  transfusion  (2)a
Dyspnea  (4)  Borderline  cholesterol
levels  (2)
Dyspnea  (4)  Late  incisional  hernia  (6)
Steatosis (14) Glucose  tolerance  (2)  Steatosis  (14)  Hypoglycemia  (6)
Disc herniation  (6) Disc  herniation  (6) AMI  at  two  different  times  (2)a
Hiatal  hernia  (2) Hiatal  hernia  (2) Surgical  site  infection  (6)a
Hypertension  (44) Hypertension  (34) Bowel  obstruction  (2)
Hypothyroidism  (4) Hypothyroidism  (4) Re-operation  (6)
Female infertility  (8) Female  infertility  (8) Breaking  stapling  (4)a
Insomnia  (2) Insomnia  (2) Severe  mal  nutrition  (2)
Oscillation of  blood
pressure  (4)
Oscillation  of  blood
pressure  (4)
Dumping  syndrome  (36)
Pre-diabetes  (6)  Pre-diabetes  (6)
Protrusion  of  the  vertebra
(2)
Protrusion  of  the  vertebra
(2)
Rheumatism  (arthritis  and
osteoarthritis)  (34)
Rheumatism  (arthritis  and
osteoarthritis)  (8)
Panic syndrome  (4)  Borderline  cholesterol
levels  (2)
Borderline  cholesterol
levels  (4)
Glucose  tolerance  (4)
Glucose  tolerance  (6)
a Events present in one single patient. AMI, acute myocardial infarction.
Table  4  Body  weight  and  BMI  before  and  after  RYGB  bariatric  surgery  in  patients  from  Rio  Verde  and  Goiânia,  Goiás,  Brazil.
Groups  Body  weight  BMI
Before  After  Before  After
3--12  months  (n  =  14)  117.82  ±  15.76  87.83  ±  13.81*** 42.10  ±  5.34  31.48  ±  5.45***
13--36  months  (n  =  13)  126.77  ±  27.30  76.45  ±  12.95*** 44.91  ±  5.67  27.32  ±  3.95***
37--60  months  (n  =  12)  118.79  ±  29.63  72.94  ±  15.43*** 46.22  ±  12.19  28.18  ±  4.73***
61--85  months  (n  =  8)  120.81  ±  15.88  76.0  ±  13.73*** 42.56  ±  5.17  26.64  ±  3.80***
Over  100  months  (n  =  3)  93.0  ±  11.36  64.67  ±  3.06* 36.26  ±  2.70  25.34  ±  2.34*
BMI: body mass index. All data are expressed as mean ± SD. Signiﬁcantly different at p < 0.05.
r BMI
o*p < 0.05 or ***p < 0.0001 signiﬁcantly different from body weight o
Two-way ANOVA and Bonferroni tests.
the  quality-of-life  of  patients  who  had  undergone  bariatric
surgery.
It  was  obtained  preliminary  results  using  the  BAROS,
a  standardized  methodology.  Despite  the  availability  of
other  speciﬁc  questionnaires  to  assess  the  quality-of-life
h
e
i
a before RYGB bariatric surgery.
f  patients  undergoing  bariatric  surgery,  the  literature
as  shown  that  the  BAROS  method  is  suitable  for  this
valuation.19--21 However,  some  limitations  were  pointed  out
n  this  study  such  as  the  self-declaration  of  occurrence  or
bsence  of  comorbidities  and  other  data,  reduced  sample
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Figure  1  Excess  weight  loss  (%EWL)  in  patients  from  Rio  Verde
and Goiânia,  Brazil,  as  a  result  of  RYGB  bariatric  surgery.  These
patients  were  stratiﬁed  according  to  the  time  of  surgery  (3
months  minimum  postoperative  time):  (A)  3--12  months;  (B)
13--36  months;  (C)  37--60  months;  (D)  61--85  months;  (E)  over
100 months.  (*When  compare  to  the  condition  before  RYGB,
p <  0.0001  for  all  groups,  t  test).
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Figure  2  Classiﬁcation  of  BAROS  method  of  50  over  18-year-
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b
ald patients  of  both  genders,  who  had  undergone  RYGB  and  had
t least  three  months  postoperative  time  in  Goiânia  and  Rio
erde,  Goiás,  Brazil.
ize  and  no  evaluation  of  patients  in  different  periods  of
ime.  On  the  other  hand,  the  results  obtained  here  were
imilar  to  other  relevant  studies22--28 and  these  data  support
ther  larger  studies.
The  majority  of  obese  patients  interviewed  showed  sat-
sfactory  results  after  RYGB  since  excess  weight  loss  was
igniﬁcantly  higher  and  was  associated  with  high  rates  of  res-
lution  of  comorbidities  due  to  obesity,  minor  post-surgical
omplications  and  improved  quality-of-life,  according  to  the
ria  and  Moorehead  criteria.17
In  relation  to  preoperative  comorbidities,  the  prevalence
as  high  (78%),  similar  to  that  observed  in  the  literature.26,27
owever,  Faria  et  al22 and  Vázquez  et  al29 found  still  higher
ates,  93  and  88.1%,  respectively.  Hypertension  was  the  most
revalent  comorbidity  (44%)  presented.  It  was  also  found
y  Vázquez  et  al29 and  Costa  et  al30 (47.7  and  63.49%,
espectively).  However,  in  the  Faria  et  al22 study,  sleep
pnea  and  dyslipidemia  were  most  prevalent.  This  rela-
ively  high  number  of  comorbidities  points  to  the  need  for
ffective  weight  loss  treatment  for  obese  patients.  In  this
ontext,  bariatric  surgery  has  been  shown  to  be  a  useful
w
a
5
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linical  approach,  since  all  patients  interviewed  in  the  stud-
es  presented  considerable  improvement  or  resolution  of
heir  medical  conditions.
Toledo  et  al31 pointed  out  the  beneﬁts  as  63.9%  of
atients  presented  reduced  hypertension  and  lipid  levels.
iga  et  al32 demonstrated  improvement  and/or  resolution  in
7,  67,  and  76%  of  patients  with  hypertension,  dyslipidemia,
nd  sleep  apnea,  respectively.  Díaz  and  Folgueras25 noted
esolution  of  the  following  comorbidities:  diabetes  (68.7%),
ypertension  (47.2%),  dyslipidemia  (43.7%)  and  sleep  apnea
36.3%).  Our  study  showed  resolution  rates  of  100,  77,  100
nd  90%,  respectively,  for  these  same  clinical  conditions.  In
ddition,  other  health  problems  related  by  patients  were
lso  improved  or  resolved  after  RYGB.  This  surgical  pro-
edure  has  been  associated  with  high  rates  of  long  lasting
edical  resolution  especially  in  metabolic  diseases  such  as
iabetes.33 In  this  regard,  recent  studies  revealed  laboratory
emission  of  diabetes  in  morbidly  and  non-severely  obese
atients  operated  with  RYGB.34,35
Although  bariatric  surgery  has  been  performed  since  the
950s,  this  surgical  practice  has  only  become  safe  and  suc-
essful  in  the  last  two  decades.  With  the  increase  in  the
umber  of  surgeries,  several  complications  have  arisen.
ence,  it  is  crucial  that  the  predictive  risk  factors  in  rela-
ion  to  morbidity  and  mortality  involving  bariatric  surgery  be
dentiﬁed  and  deﬁned.36 Furthermore,  it  is  worth  noting  that
aparoscopy  instead  of  open  surgery  has  greatly  decreased
he  occurrence  of  severe  surgical  complications.32
In  our  study,  60%  of  respondents  experienced  post-
urgical  complications.  Of  these  the  dumping  syndrome  was
ost  prevalent  (36%),  similar  to  another  study  with  50
atients  who  underwent  RYGB  that  found  an  incidence  of
2%.18 This  ﬁnding  emphasizes  the  need  for  nutritional  mon-
toring  during  the  postoperative  follow-up.18,37 In  another
tudy,  hair  loss  (73.3%)  was  most  prevalent,  followed  by
umping  syndrome  (66.6%).27 These  studies  highlight  the
resence  of  minor  complications  after  bariatric  surgery,  but
o  not  take  from  the  beneﬁts  derived  from  a  reduction  in
ody  measurements.10
The  weight  loss  parameter  is  one  of  the  crucial  end-
oints  in  quality-of-life  assessment.  The  patients’  mean
reoperative  weight  and  BMI  were  119.37  ±  18.44  kg  and
3.54  ±  5.33  kg/m2,  respectively,  with  a  prevalence  of  mor-
id  obesity  (48%),  in  consonance  with  other  studies.27,31
y  contrast,  after  the  RYGB  bariatric  surgery  these  same
arameters  decreased  signiﬁcantly  to  78.01  ±  11.06  kg  and
8.46  ±  3.61  kg/m2,  respectively.  Weight  loss  associated
ith  RYGB  is  multifactorial  and  well-understood,  occurring
ue  to  changes  in  the  entero-endocrine  axis  and  restric-
ion  of  food  intake  by  virtue  of  a  smaller  gastric  pouch  and
alabsorptive  effects  resulting  from  the  distortion  of  the
astrointestinal  anatomy.18
The  excess  weight  loss  percentage  (%EWL),  after  13
onths  postoperative  time  was  similar  to  that  of  other  stud-
es,  which  found  60%  EWL  after  6  months  as  compared  to
5%,  12  months  after  surgery.38,39 Weight  loss  after  RYGB
ariatric  surgery  can  reach  65--80%  within  12--18  months
fter  surgery.  However,  some  weight  gain  usually  occurs
ithin  three  to  ﬁve  years  afterwards.  A  5-year  follow-up
fter  surgery  showed  an  average  EWL  oscillating  between
0  and  60%.4 According  to  Suter  et  al,28 after  the  same
eriod,  74.9%  of  patients  had  an  EWL  of  at  least  50%  while
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Harakeh  et  al19 found  an  average  EWL  of  75.3%,  18  months
after  bariatric  surgery.
For  this  group  of  patients,  especially  the  morbidly  obese,
their  health-related  quality-of-life  is  poor  and  expectations
of  improving  it  are  a  reason  why  patients  frequently  seek
help  through  bariatric  surgery.40 In  relation  to  quality-of-
life,  the  patients  interviewed  in  this  study  presented  very
good  (24%)  or  excellent  (66%)  outcomes  in  the  ﬁnal  BAROS
score.  Harakeh  et  al19,  Faria  et  al22 and  González  et  al23
also  found  a  high  percentage  of  patients  with  excellent
outcomes  (approximately  60%),  while  the  ﬁnal  scores  of
Dadan  et  al24 and  Díaz  and  Folgueras25 rated  as  very  good
(57  and  54%,  respectively).  Recently,  another  study  using
SF-36  and  Obesity-related  Problems  scale  (OP)  instruments
showed  patients  operated  with  RGYB  have  better  scores  in
most  aspects  of  quality-of-life  compared  to  non-operated
obese  individuals,  although  they  did  not  achieve  the  levels
of  the  general  population.40 As  seen  here,  this  study  showed
that  improving  obesity-related  comorbidity  is  a  prerequisite
for  good  quality-of-life.  While  improved  QOL  is  triggered  by
weight  loss,  patients  are  also  instructed  to  implement  diet
and  lifestyle  changes  after  gastric  bypass  surgery.41 Thus,
they  gain  quality-of-life  through  healthier  behavior  and  this
may  even  be  assimilated  by  their  partners.41,42
In  addition,  psychosocial  relations  improved  for  several
patients  interviewed,  since  this  surgery  enhances  self-
esteem  and  promotes  healthier  living  in  society.  Although
obesity  is  a  health  problem  in  current  society,  it  is  also  an
esthetic  problem,  which  can  affect  the  obese  both  emotion-
ally  and  socially,  and  thus  interfere  in  their  quality-of-life.43
On  considering  the  characteristics  of  the  population  in
this  study,  in  addition  to  great  body  mass,  there  was  a
considerable  prevalence  of  women,  also  observed  by  other
authors.30,44 In  their  studies,  approximately  80%  of  patients
were  female,  justiﬁed  by  the  greater  demand  for  treatment
among  women.  Prevedello  et  al1 argue  that  this  prevalence
may  be  related  to  the  fact  that  obese  women  are  more  moti-
vated  to  lose  weight  than  obese  men,  perhaps  as  a  result  of
esthetic  pressures.  In  addition,  the  average  age  of  respon-
dents  in  this  study  was  about  40  years,  which  is  also  similar
to  that  of  other  studies.25,29,44 Approximately  65%  were  mar-
ried,  and  presented  the  same  proﬁle  as  the  group  of  patients
studied  by  Guimarães  et  al26 And  most  of  the  respondents
were  university  graduates  (66%),  with  a  higher  education
level,  similar  to  that  found  in  the  literature.1
A
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Although  this  is  a  preliminary  study  as  a  basis  for  further
tudies  with  larger  numbers  of  patients  and/or  a  long-term
ollow-up,  results  obtained  indicated  that  the  RYGB  could
e  a  successful  surgical  procedure  to  promote  a  satisfac-
ory  and  sustained  reduction  in  the  body  measurements  of
orbidly  obese  patients  from  Goiás,  Brazil.  Furthermore,
he  ﬁnal  BAROS  scores  showed  improvements  in  associ-
ted  comorbidity  and  also  in  the  quality-of-life  of  these
atients.
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utcome System (BAROS) Questionnaire
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